InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Explore the complete record of transactions filed by Valliant John, Chairman & CEO. Director active across 1 company, notably Fusion Pharmaceuticals Inc.. Cumulatively, 17 reports have been published. Breakdown: 0 buy · 17 sells. Total volume traded: €388k. Activity tracked since 15 February 2022. The latest transaction was filed on 25 April 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations17 total
2,036 shares@ US$6.033.0% of flowCommon StockSEC:0001209191-22-025783:0
367 shares@ US$6.020.5% of flowCommon StockSEC:0001209191-22-025469:0
2,600 shares@ US$7.374.5% of flowCommon StockSEC:0001209191-22-024330:0
100 shares@ US$7.580.2% of flowCommon StockSEC:0001209191-22-023861:0
1,000 shares@ US$7.751.8% of flowCommon StockSEC:0001209191-22-023124:0
300 shares@ US$7.520.5% of flowCommon StockSEC:0001209191-22-022034:0
500 shares@ US$7.420.9% of flowCommon StockSEC:0001209191-22-021487:0
4,000 shares@ US$7.537.0% of flowCommon StockSEC:0001209191-22-020948:0
900 shares@ US$7.511.6% of flowCommon StockSEC:0001209191-22-020316:0
1,300 shares@ US$6.962.1% of flowCommon StockSEC:0001209191-22-019224:0
822 shares@ US$6.941.3% of flowCommon StockSEC:0001209191-22-018455:0
8,400 shares@ US$7.3214.3% of flowCommon StockSEC:0001209191-22-017150:0
847 shares@ US$7.371.4% of flowCommon StockSEC:0001209191-22-015555:0
2,500 shares@ US$7.414.2% of flowCommon StockSEC:0001209191-22-013791:0
4,898 shares@ US$7.888.7% of flowCommon StockSEC:0001209191-22-012344:0
12,600 shares@ US$8.3323.9% of flowCommon StockSEC:0001209191-22-010918:0
12,600 shares@ US$8.33100.0% of flowCommon StockSEC:0001209191-22-010918
17 of 17 declarations
About Valliant John
Valliant John is an insider at Fusion Pharmaceuticals Inc.
